Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 2 | N/A | N/A |
| Receivables | N/A | 1 | N/A |
| Inventories | N/A | 219 | N/A |
| Other current assets | 54 | 55 | 0 |
| TOTAL | $104 | $383 | $N/A |
| Non-Current Assets | |||
| PPE Net | 0 | 359 | N/A |
| Intangibles | 0 | 1,696 | 0 |
| Other Non-Current Assets | 0 | 107 | 0 |
| TOTAL | $0 | $2,163 | $N/A |
| Total Assets | $104 | $2,546 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 1,366 | 20 | N/A |
| Accounts payable and accrued liabilities | 159 | 154 | 0 |
| Accrued Expenses | 137 | 102 | N/A |
| TOTAL | $2,083 | $844 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | N/A | 494 | N/A |
| Deferred Revenues | N/A | 58 | N/A |
| TOTAL | $N/A | $494 | $N/A |
| Total Liabilities | $2,083 | $1,338 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | 1 | N/A |
| Retained earnings | -14,875 | -11,849 | N/A |
| Other shareholders' equity | -1,428 | -1,056 | 0 |
| TOTAL | $-1,979 | $1,208 | $N/A |
| Total Liabilities And Equity | $104 | $2,546 | $0 |